SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   FORM 10-QSB

(Mark One)
 X   QUARTERLY  REPORT  PURSUANT  TO  SECTION  13  OR  15(d) OF THE SECURITIES
---
EXCHANGE  ACT  OF  1934

For  the  quarterly  period  ended                   June 30, 2002
                                  ----------------------------------------------

     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
---
EXCHANGE ACT OF 1934

For  the  transition  period  from                         to
                                    ----------------------    ------------------

Commission  file  number                         0-16286
                        --------------------------------------------------------

                              MEDPLUS CORPORATION
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

Delaware                                                        95-4082020
-------------------------------                           ----------------------
(State or other jurisdiction of                               (IRS Employer
 incorporation or organization)                           identification number)

121 East Pikes Peak, Ste. 355, Colorado Springs,  Colorado            80903
------------------------------------------------------------       ----------
(address of principle executive offices)                           (Zip Code)

                                  719-447-8856
--------------------------------------------------------------------------------
              (Registrants telephone number, including area code)


--------------------------------------------------------------------------------
Former  name,  former  address  and  former  fiscal  year, if changed since last
report)

Indicate by check mark whether the registrant (1) has filed all reports required
to  be  filed  by  section  13  or 15 (d) of the Securities Exchange Act of 1934
during  the  preceding 12 months (or for such shorter period that the registrant
was  required  to  file  such  reports), and (2) has been subject to such filing
requirements  for  the  past  90  days.     Yes       No  X
                                                ---      ---

                       APPLICABLE ONLY TO ISSUERS INVOLVED
                        IN BANKRUPTCY PROCEEDINGS DURING
                            THE PRECEDING FIVE YEARS

Indicate  by  check  mark  whether  the  registrant  has filed all documents and
reports  required to be filed by section 13 or 15 (d) of the Securities Exchange
Act  of  1934 subsequent to the distribution requirements under a plan confirmed
by  a  court.   Yes       No
                    ---      ---

                      APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate  the  number  of  shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

Class                                     Outstanding at October 15, 2002
--------------------------------------------------------------------------------
Common Stock, Par-Value
--------------------------------------------------------------------------------
$.001 per share                           32,838,958
--------------------------------------------------------------------------------


<PAGE>
<TABLE>
<CAPTION>
                               MEDPLUS CORPORATION

                              REPORT ON FORM 10-QSB


                                TABLE OF CONTENTS



PART I                                                           PAGE NUMBER
------                                                           -----------
<S>                                                              <C>
ITEM 1. -  FINANCIAL INFORMATION

           Balance Sheets at June 30, 2002
              and March 31, 2002. . . . . . . . . . . . . . . . . . . 3

           Statements of Operations for the
              Three Months Ended June 30, 2002
              and June 30, 2001 . . . . . . . . . . . . . . . . . . . 4

           Statements of Cash Flows for the
              Three Months Ended June 30, 2002
              and June 30, 2001 . . . . . . . . . . . . . . . . . . . 5

        Notes to Financial Statements . . . . . . . . . . . . . . . . 6

ITEM  2. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE
           FINANCIAL CONDITION AND RESULTS OF
           OPERATIONS . . . . . . . . . . . . . . . . . . . . . . . . 7

PART II
-------

           Other Information. . . . . . . . . . . . . . . . . . . . . 8

           Signature Page . . . . . . . . . . . . . . . . . . . . . . 8
</TABLE>


                                        2
<PAGE>
<TABLE>
<CAPTION>
                                          PART I
                              ITEM 1.  FINANCIAL INFORMATION
                                   MEDPLUS CORPORATION

BALANCE SHEETS

ASSETS                                                   June 30, 2002    March 31, 2002
                                                          (Unaudited)
<S>                                                     <C>              <C>
CURRENT ASSETS:
Cash and cash equivalents                               $          -0-   $           -0-
Note receivable                                                    -0-               -0-
                                                        ---------------  ----------------

Total current assets                                               -0-               -0-
                                                        ---------------  ----------------

PROPERTY:
Office Equipment                                                   -0-               -0-
Furniture and Fixtures                                             -0-               -0-
                                                        ---------------  ----------------

Total                                                              -0-               -0-
Less accumulated depreciation                                      -0-               -0-
                                                        ---------------  ----------------

TOTAL ASSETS                                            $          -0-   $           -0-
                                                        ===============  ================

LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:

Accrued Expenses                                        $      113,885   $       113,885
Notes payable to related parties                               116,741           116,741
Accrued Payroll Taxes                                           94,500            94,500
Shareholder Loans                                                3,035             3,035
Accured Legal Fees/Settlement                                  118,670           118,670
                                                        ---------------  ----------------

Total liabilities                                              446,831           446,831
                                                        ---------------  ----------------


SHAREHOLDERS' EQUITY:
Preferred stock, $.001 par value;
  authorized 2,000,000 shares;no shares outstanding
Common stock, $.001 par value;
  authorized, 100,000,000 shares;
  19,499,228 issued and outstanding                             25,839            25,839
Additional paid in capital                                  10,638,147        10,638,147
Accumulated deficit                                        (11,110,817)      (11,110,817)
                                                        ---------------  ----------------

Net shareholders' equity (deficit)                            (446,831)         (446,831)
                                                        ---------------  ----------------

TOTAL                                                   $          -0-   $           -0-
                                                        ===============  ================
</TABLE>


                 See accompanying notes to financial statements


                                        3
<PAGE>
<TABLE>
<CAPTION>
                      MEDPLUS CORPORATION
                    STATEMENTS OF OPERATIONS
                          (UNAUDITED)


                                    Three Month Period
                                      Ended June 30,
                                 ------------------------
                                    2001         2002
                                 -----------  -----------
<S>                              <C>          <C>
PATIENT FINANCE REVENUES:        $       -0-  $       -0-
-------------------------

EXPENSES:
---------
General and Administrative               -0-          -0-
Sales and Marketing                      -0-          -0-
Professional/Conract Services            -0-          -0-

Total expenses                           -0-          -0-
                                 -----------  -----------

Loss from Operations                     -0-          -0-

OTHER INCOME (Expences)
-----------------------

Interest Expense
Debt Forgiveness                      12,621          -0-

Net loss/Income from operation        11,515          -0-
                                 -----------  -----------

Loss Per Share From Operations           nil          nil
                                 ===========  ===========

Weighted average number of
  common shares outstanding       15,500,500   22,669,093
</TABLE>


                      See accompanying financial statements


                                        4
<PAGE>
<TABLE>
<CAPTION>
                               MEDPLUS CORPORATION
                            STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)


                                                          Three Month Period
                                                            Ended June 30,
                                                          -------------------
                                                   2001          2002
                                                   -----  -------------------
<S>                                                <C>    <C>

CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss)                                  $ -0-  $               -0-
Changes in operating assets and liabilities
  Depreciation
  Accounts receivable
  Other Current Assets
  Increase (decrease) in liabilities:
  Accounts payable                                   -0-                  -0-
  Other Liabilities
  Total Adjustments
Net cash provided (used) by operating activities     -0-                  -0-

CASH FLOWS FROM INVESTING ACTIVITIES:
  Fixed Assets
Net cash provided (used) by investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
  Note Payable - Related Party                       -0-                  -0-
  Note Payable
  Stock Issued for Debt Reduction
Net Cash Provided for financing activities

Increase (decrease) in cash
Cash  beginning of period

Cash and cash equivalents at end of period         $ -0-  $               -0-
                                                   =====  ===================
</TABLE>


                 See accompanying notes to financial statements


                                        5
<PAGE>
                               MEDPLUS CORPORATION
                    NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

1.   GOING  CONCERN
     --------------
     The  Company's  financial  statements are prepared using generally accepted
     accounting principles applicable to a going concern, which contemplates the
     realization  of  assets and liquidation of liabilities in the normal course
     of  business.  However, the Company does not have significant cash or other
     material  assets,  nor  does  it  have  an  established  source of revenues
     sufficient  to  cover  its operating costs and to allow it to continue as a
     going  concern.  These  factors raise substantial doubt about the Company's
     ability  to  continue  as  a going concern. The Company's continuation as a
     going  concern is dependent upon its ability to generate sufficient cash to
     meet  its  obligations  on  a  timely  basis, to obtain financing as may be
     required,  and  ultimately  to  attain successful operations. Management is
     continuing its efforts to obtain additional funds needed for the successful
     operation  of  the  Company.

2.   BASIS  OF  PRESENTATION
     -----------------------
     The  accompanying  unaudited  consolidated  financial statements of MEDPLUS
     CORPORATION  contain  all  adjustments (consisting of only normal recurring
     adjustments)  which,  in the opinion of management are necessary to present
     fairly  the  financial position of the Company as of the periods ended June
     30,  2002  and  March  31, 2002, and the results of operations and its cash
     flows  for  the  three month periods ended June 30, 2001 and June 30, 2002.
     Certain information and footnote disclosures normally included in financial
     statements have been condensed or omitted pursuant to rules and regulations
     of the Securities and Exchange Commission, although the registrant believes
     that  the disclosures in the consolidated financial statements are adequate
     to  make  the  information  presented  not  misleading.

     INCOME  TAXES
     -------------
     Deferred  income  taxes arise from temporary differences resulting from the
     Company's  subsidiary  utilizing  the  cash  basis  of  accounting  for tax
     purposes  and  the accrual basis for financial reporting purposes. Deferred
     taxes  are  classified  as  current  or  non-current,  depending  on  the
     classification of the assets and liabilities to which they relate. Deferred
     taxes  arising  from timing differences that are not related to an asset or
     liability are classified as current or non-current depending on the periods
     in  which  the  timing  differences  are expected to reverse. The Company's
     previous  principal  temporary  differences  relate to revenue and expenses
     accrued  for  financial  purposes,  which  are  not  taxable  for financial
     reporting purposes. The Company's material temporary differences consist of
     bad  debt  expense  recorded  in  the  financial  statements  that  is  not
     deductible  for  tax  purposes  and differences in the depreciation expense
     calculated for financial statement purposes and tax purposes
     As  of  March 31, 2001, the Company has net operating loss carryforwards of
     approximately  $8,632,000 which expire beginning in fiscal year 2000. As of
     March  31,  2001,  the Company has recorded a valuation allowance to reduce
     existing  deferred  tax  assets  since  the  assets  are  not  likely to be
     realized.

3.   COMPUTATION  OF  NET  LOSS  PER  SHARE
     --------------------------------------
     Net loss per share is computed by dividing net loss by the weighted average
     number  of shares of common stock outstanding. Options and warrants are not
     included  because  their  effect  would  be  antidilutive.

4.   NOTES  PAYABLE  TO  RELATED  PARTIES
     ------------------------------------
     Notes payable to related parties, all of which are considered to be current
     liabilities  by  their terms or due to default, consist of the following at
     March  31,  2002:


                                        6
<PAGE>
     Unsecured  note payable to a shareholder and former officer of the Company,
     non-interest  bearing, due in equal monthly installments of $2,000 from May
     1996 through April 1997 with a final installment of $123,288 payable on May
     1997.  This note is recorded net of unamortized discount of $5,074 at March
     31,  1997  to  reflect  an effective interest rate of 18%. Payments on this
     note  are  in  default.
                                                                        $116,741
     Unsecured  note payable to shareholder of the Company bearing interest at a
     range  between  10% to 17% depending on shareholder's credit card rate. The
     note  is  payable  on  demand  and  in  default.
                                                                          $3,035
     Total                                                              $119,776


                ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                ------------------------------------------------
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                  ---------------------------------------------

     LIQUIDITY  AND  CAPITAL  RESOURCES
     ----------------------------------

     At  June 30, 2002 the Company had working capital of ($446,832) compared to
     working  capital  of  ($446,832)  at  March  31,  2002. The working capital
     remained the same due to the Company not making any significant changes for
     these periods. The Company's current liabilities are higher than its assets
     due  primarily  to  borrowings  in  the  form  of  promissory  notes  from
     shareholders of the Company and related parties along with accrued payables
     and  expenses.

     The  Company's liquidity position is severely strained. Liquidity needs are
     currently  being  met from revenues and short-term borrowing in the form of
     promissory  notes.  Because the Company has not achieved positive cash flow
     from  its operating activities, the company ceased normal operations in May
     1998.  The  Company's  ability to continue operations is dependent upon its
     ability  to  raise  additional equity and/or debt financing. This and other
     factors  raise substantial doubt as to the Company's ability to continue as
     a  going  concern.  Management  believes  the Company needs approximately $
     250,000  in equity or debt financing in order to sustain operations for the
     next  twelve  months following the period ended June 30, 2002. Although the
     Company  is  actively  engaged  in  activities  with intent to raise equity
     and/or debt financing in order to meet its long-term liquidity needs, there
     can  be  no  assurance  that  the  Company  will  be able to consummate the
     transaction  and/or raise the additional financing necessary for continuing
     operations

     RESULTS  OF  OPERATIONS
     -----------------------

     Revenue  derived  from  the  sale of products from the Company's continuing
     operations  was  zero  for  the  three  month period ended June 30, 2002 as
     compared  to  $4,614  in operating revenue for the three month period ended
     June  30,  2001. The Company's revenue decrease over the three month period
     ended  June  30,  2002  is primarily attributable to the decline in patient
     financing  with  no  employees  to  support  the  financing  activities.

     There  were  no  General and Administrative expenses for operations for the
     three  month  period ended June 30, 2001. There were no Sales and Marketing
     espenses  for  operations  for  the  three month period ended June 30, 2001


                                        7
<PAGE>
                                     PART II
                                OTHER INFORMATION

ITEM 1.   LEGAL  PROCEEDINGS
          ------------------

          None

ITEM 2.   CHANGES  IN  SECURITIES
          -----------------------

          None

ITEM 3.   DEFAULTS  UPON  SENIOR  SECURITIES
          ----------------------------------

          None

ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS
          -----------------------------------------------------

          None

ITEM 5.   OTHER  INFORMATION
          ------------------

OFFER  AND COMPRIMISE ACCEPTED - On August 7, 2001, the Internal Revenue Service
accepted  an offer of $ 94,500 to settle outstanding payroll tax liabilities and
release liens associated with payroll taxes from 1996 through 1999. The offer is
due  to be paid in January 2002. The accrued payroll taxes have been adjusted in
these  financial  statements  to  reflect  this settlement. This remains unpaid.

ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K
          -------------------------------------

          a.  Exhibits                    b.  Reports on Form 8-k
              None                            None

Signatures
----------

Pursuant  to  the  requirements  of the Securities and Exchange Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  thereunto  duly  authorized.

                                                 MEDPLUS CORPORATION


Date:  October 16, 2002                          \By\ Tim C. DeHerrera
                                                 ----------------------
                                                 Tim C. DeHerrera
                                                 Director



                                        8
<PAGE>